Q1 2016 13F Holders as of 3/31/2016
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
149
-
Total 13F shares, excl. options
-
14.2M
-
Shares change
-
-309K
-
Total reported value, excl. options
-
$418M
-
Value change
-
-$10.1M
-
Put/Call ratio
-
1.72
-
Number of buys
-
95
-
Number of sells
-
-42
-
Price
-
$29.37
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q1 2016
163 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q1 2016.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 149 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 14.2M shares
of 27.8M outstanding shares and own 51.23% of the company stock.
Largest 10 shareholders include Apex Capital Management (1.29M shares), BlackRock Fund Advisors (1.18M shares), EAGLE ASSET MANAGEMENT INC (994K shares), Krensavage Asset Management, LLC (883K shares), ACADIAN ASSET MANAGEMENT LLC (808K shares), FMR LLC (649K shares), VANGUARD GROUP INC (631K shares), STATE STREET CORP (582K shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (416K shares), and BlackRock Institutional Trust Company, N.A. (374K shares).
This table shows the top 149 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.